Health Law Scan

The Federal Trade Commission (FTC), State of California, and Utah Division of Consumer Protection recently filed a sweeping complaint against telemedicine company Hims & Hers Health, Inc., using federal and state consumer-protection laws to assert allegations against its direct-to-consumer telehealth business. The case is notable as regulators are not relying on a traditional health-privacy statute but rather general consumer-protection laws to challenge health-data advertising practices and aspects of Hims’s subscription model. 

Through the issuance of Inauguration Day executive orders, the Trump Administration signaled its apparent intent to tackle drug pricing reforms over the next four years. However, Biden-era policies are likely to limit a comprehensive overhaul of existing reforms in the near term.